"evolocumab" meaning in All languages combined

See evolocumab on Wiktionary

Noun [English]

IPA: /ˌɛv.əˈlɑk.jəˌmæb/ [General-American]
Etymology: From [Term?] + -c- (“cardiovascular”) + -umab (“human monoclonal antibody”). Etymology templates: {{af|en||-c-|-umab|t2=cardiovascular|t3=human monoclonal antibody}} [Term?] + -c- (“cardiovascular”) + -umab (“human monoclonal antibody”) Head templates: {{en-noun|-}} evolocumab (uncountable)
  1. (pharmacology) A human monoclonal antibody designed for the treatment of hyperlipidemia. Wikipedia link: evolocumab Tags: uncountable Categories (topical): Pharmaceutical drugs

Download JSON data for evolocumab meaning in All languages combined (2.0kB)

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "",
        "3": "-c-",
        "4": "-umab",
        "t2": "cardiovascular",
        "t3": "human monoclonal antibody"
      },
      "expansion": "[Term?] + -c- (“cardiovascular”) + -umab (“human monoclonal antibody”)",
      "name": "af"
    }
  ],
  "etymology_text": "From [Term?] + -c- (“cardiovascular”) + -umab (“human monoclonal antibody”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "evolocumab (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms interfixed with -c-",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms suffixed with -umab",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Pharmaceutical drugs",
          "orig": "en:Pharmaceutical drugs",
          "parents": [
            "Drugs",
            "Matter",
            "Pharmacology",
            "Chemistry",
            "Nature",
            "Biochemistry",
            "Medicine",
            "Sciences",
            "All topics",
            "Biology",
            "Fundamental"
          ],
          "source": "w"
        }
      ],
      "examples": [
        {
          "ref": "2015 July 24, Andrew Pollack, “New Drug Sharply Lowers Cholesterol, but It’s Costly”, in New York Times",
          "text": "So was Repatha, or evolocumab, a similar drug developed by Amgen that is expected to win F.D.A. approval by the end of August.",
          "type": "quotation"
        }
      ],
      "glosses": [
        "A human monoclonal antibody designed for the treatment of hyperlipidemia."
      ],
      "id": "en-evolocumab-en-noun-~ar5~ML~",
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "human",
          "human"
        ],
        [
          "monoclonal antibody",
          "monoclonal antibody"
        ],
        [
          "hyperlipidemia",
          "hyperlipidemia"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A human monoclonal antibody designed for the treatment of hyperlipidemia."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "evolocumab"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/ˌɛv.əˈlɑk.jəˌmæb/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "word": "evolocumab"
}
{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "",
        "3": "-c-",
        "4": "-umab",
        "t2": "cardiovascular",
        "t3": "human monoclonal antibody"
      },
      "expansion": "[Term?] + -c- (“cardiovascular”) + -umab (“human monoclonal antibody”)",
      "name": "af"
    }
  ],
  "etymology_text": "From [Term?] + -c- (“cardiovascular”) + -umab (“human monoclonal antibody”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "evolocumab (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English 5-syllable words",
        "English entries with incorrect language header",
        "English lemmas",
        "English nouns",
        "English term requests",
        "English terms interfixed with -c-",
        "English terms suffixed with -umab",
        "English terms with IPA pronunciation",
        "English terms with quotations",
        "English uncountable nouns",
        "en:Pharmaceutical drugs"
      ],
      "examples": [
        {
          "ref": "2015 July 24, Andrew Pollack, “New Drug Sharply Lowers Cholesterol, but It’s Costly”, in New York Times",
          "text": "So was Repatha, or evolocumab, a similar drug developed by Amgen that is expected to win F.D.A. approval by the end of August.",
          "type": "quotation"
        }
      ],
      "glosses": [
        "A human monoclonal antibody designed for the treatment of hyperlipidemia."
      ],
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "human",
          "human"
        ],
        [
          "monoclonal antibody",
          "monoclonal antibody"
        ],
        [
          "hyperlipidemia",
          "hyperlipidemia"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A human monoclonal antibody designed for the treatment of hyperlipidemia."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "evolocumab"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/ˌɛv.əˈlɑk.jəˌmæb/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "word": "evolocumab"
}

This page is a part of the kaikki.org machine-readable All languages combined dictionary. This dictionary is based on structured data extracted on 2024-06-04 from the enwiktionary dump dated 2024-05-02 using wiktextract (e9e0a99 and db5a844). The data shown on this site has been post-processed and various details (e.g., extra categories) removed, some information disambiguated, and additional data merged from other sources. See the raw data download page for the unprocessed wiktextract data.

If you use this data in academic research, please cite Tatu Ylonen: Wiktextract: Wiktionary as Machine-Readable Structured Data, Proceedings of the 13th Conference on Language Resources and Evaluation (LREC), pp. 1317-1325, Marseille, 20-25 June 2022. Linking to the relevant page(s) under https://kaikki.org would also be greatly appreciated.